Chronic Renal Insufficiency Clinical Trial
Official title:
Can the Peritoneal Cavity be a Source of Regulatory B Cells to Treat Auto-immune Disease?
Some subsets of lymphocytes are able to inhibit immune response and thus, could be used to control auto-immune diseases and transplant reject. In mice, the main source of those anti-inflammatory lymphocytes is the peritoneal cavity. No data are available in human. This study aims at exploring the presence of those anti-inflammatory lymphocytes in human peritoneal cavity and at determine how to expand those cells.
B cells will be collected during procedures planned for patients' standard care. Peritoneal
fluid and peripheral blood of patients will be collected during coelioscopy for exploration
of ovarian cysts or dialysis for treatment of chronic renal insufficiency.
Regulatory B cells (Breg cells) will be measured in peritoneal fluid and in peripheral blood
after in vitro stimulation and assessment of intracellular interleukin-10 by flow cytometry.
Proportion of Breg cells among B cells will be compared between peritoneal fluid and
peripheral blood in both groups.
Different protocols to induce differentiation of B cells into Breg cells will be tested and
compared.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00968877 -
Vitamin D and Chronic Renal Insufficiency
|
Phase 3 | |
| Terminated |
NCT00701714 -
Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
|
Phase 3 | |
| Completed |
NCT00998972 -
N-acetyl-cysteine (NAC) and Kidney Graft Function
|
Phase 3 | |
| Completed |
NCT00716573 -
Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure
|
Phase 4 | |
| Recruiting |
NCT04334707 -
Kidney Precision Medicine Project
|
||
| Completed |
NCT02203084 -
Social Determinants in Chronic Disease in British Columbia
|
N/A | |
| Recruiting |
NCT02147782 -
Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
|
||
| Completed |
NCT01029002 -
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
|
Phase 3 | |
| Completed |
NCT00742716 -
Safety Study of CTA018 Injection to Treat Stage 5 Chronic Kidney Disease
|
Phase 2 | |
| Completed |
NCT00095056 -
An Investigational Drug in Patients With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (0431-028)(COMPLETED)
|
Phase 3 | |
| Completed |
NCT00223548 -
MESNA for Prevention of Acute Deterioration of Renal Function Following Contrast Agent Application
|
Phase 2 | |
| Completed |
NCT01574157 -
Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.
|
N/A | |
| Active, not recruiting |
NCT02751099 -
Bone and Cardiovascular Disease After Kidney Transplant
|
||
| Recruiting |
NCT02002585 -
Renal Protection Using Sympathetic Denervation in Patients With Chronic Kidney Disease
|
Phase 2 | |
| Completed |
NCT01245374 -
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
|
Phase 4 | |
| Completed |
NCT01252810 -
Safety Study of GE-145 320 mg I/mL Injection vs. Iopamidol 370 mg I/mL in Elderly Subjects Undergoing Coronary Procedure
|
Phase 2 | |
| Completed |
NCT00792857 -
Comparison of I.V. CTAP201 and Doxercalciferol (Hectorol) in Subjects With Chronic Kidney Disease (CKD) and Secondary Hyperparathyroidism (SHPT)
|
Phase 1 | |
| Completed |
NCT00888069 -
Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects
|
Phase 1 | |
| Completed |
NCT00369733 -
STAAR-3 Clinical Study
|
Phase 4 | |
| Recruiting |
NCT06362759 -
A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP
|
Phase 2 |